Enhancing the Viability, Function, and Safety, of Genetically-Enhanced NK Cells Within the Solid Tumor Microenvironment With IL-15 and a Suicide Gene |
Baylor College of Medicine / Robin Parihar, MD, PhD |
Young Investigator Grants |
2015 |
Texas |
Natural Killer T cells with an IL-15-armored GD2-specific CAR for Children with Neuroblastoma |
Baylor College of Medicine / Andras Heczey, MD |
Bio-Therapeutic Impact Award |
2017 |
Texas |
Mechanisms of LYL1-associated T-ALL development |
Baylor College of Medicine / Margaret Goodell, PhD |
Innovation Grants |
2012 |
Texas |
Understanding factors contributing to retention in care among children with cancer in sub-Saharan Africa |
Baylor College of Medicine / Mark Zobeck, MD, PhD |
Psychosocial Launch Grant |
2019 |
Texas |
Role of H3.3-G34R mutation in pediatric high-grade glioma |
University of Texas M.D. Anderson Cancer Center / Jian Hu, PhD |
Innovation Grants |
2021 |
Texas |
Genetically Engineered T Cells as Therapy for Pediatric Glioma |
Baylor College of Medicine / Giedre Krenciute, PhD |
Young Investigator Grants |
2016 |
Texas |
Fatigue and Carnitine Levels over Eight Cycles of Chemotherapy in Children and Adolescents.
|
Baylor College of Medicine / Marilyn Hockenberry |
Nurse Researcher Grants |
2008 |
Texas |
The Role of Pyruvate Dehydrogenase in Leukemia |
University of Texas Southwestern Medical Center at Dallas / Michalis Agathocleous, PhD |
'A' Award Grants |
2018 |
Texas |
Combining Oncolytic Vaccinia Virus with GD2.CAR-modified Vaccinia Virus-specific T-cells for the Treatment of Relapsed Neuroblastoma and Sarcoma |
Baylor College of Medicine / Cliona Rooney, PhD |
Reach Grants |
2013 |
Texas |
Using Neurofibromatosis-1 (NF1) to understand Pediatric Brain Tumor Initiation |
MD Anderson Cancer Center / Yuan Pan, PhD |
Young Investigator Grants |
2020 |
Texas |